These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 9221377

  • 1. [Optimal antiviral therapy of chronic hepatitis caused by hepatitis C virus].
    Cooreman MP, Stadhouders P.
    Orv Hetil; 1997 Jun 01; 138(22 Suppl 1):1476-82. PubMed ID: 9221377
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M, Ken A, Okuno T.
    Cancer; 1999 May 01; 85(9):1943-50. PubMed ID: 10223234
    [Abstract] [Full Text] [Related]

  • 4. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.
    Liver Transpl; 2004 Feb 01; 10(2):199-207. PubMed ID: 14762857
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
    Pramoolsinsap C, Poovorawan Y, Sura T, Theamboonlers A, Busagorn N, Kurathong S.
    Southeast Asian J Trop Med Public Health; 1998 Sep 01; 29(3):480-90. PubMed ID: 10437943
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N, Rizzetto M.
    Minerva Gastroenterol Dietol; 2005 Mar 01; 51(1):31-46. PubMed ID: 15756144
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C.
    Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, Watanabe H.
    J Gastroenterol Hepatol; 2006 Jan 01; 21(1 Pt 1):122-8. PubMed ID: 16706823
    [Abstract] [Full Text] [Related]

  • 12. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G.
    Ital J Gastroenterol Hepatol; 1997 Aug 01; 29(4):343-50. PubMed ID: 9476189
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapy of hepatitis C: patients with cirrhosis.
    Schalm SW, Fattovich G, Brouwer JT.
    Hepatology; 1997 Sep 01; 26(3 Suppl 1):128S-132S. PubMed ID: 9305677
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul 01; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 17. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
    Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Takemura S, Shiomi S, Kinoshita H.
    Gan To Kagaku Ryoho; 2001 Dec 01; 28(13):1975-9. PubMed ID: 11791377
    [Abstract] [Full Text] [Related]

  • 18. Acute hepatitis C: prevention and treatment.
    Ozaras R, Tahan V.
    Expert Rev Anti Infect Ther; 2009 Apr 01; 7(3):351-61. PubMed ID: 19344247
    [Abstract] [Full Text] [Related]

  • 19. The natural history of hepatitis C virus infection.
    Al-Quaiz MN, Madani TA, Karawi MA.
    Saudi Med J; 2003 Jul 01; 24 Suppl 2():S67-70. PubMed ID: 12897903
    [Abstract] [Full Text] [Related]

  • 20. [Chronic hepatitis C: virologic and immunologic aspects and questions of therapy].
    Pár A.
    Orv Hetil; 1997 Jun 01; 138(22 Suppl 1):1465-76. PubMed ID: 9221376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.